The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Chemotherapy-Induced Peripheral Neuropathy: Prevention and Treatment
Abstract
Chemotherapy-induced peripheral neuropathy (CIPN) is a common, dose-limiting side effect of many chemotherapeutic agents. Although many therapies have been investigated for the prevention and/or treatment of CIPN, there is no well-accepted proven therapy. In addition, there is no universally accepted, well-validated measure for the assessment of CIPN. The agents for which there are the strongest preliminary data regarding their potential efficacy in preventing CIPN are intravenous calcium and magnesium (Ca/Mg) infusions and glutathione. Agents with the strongest supporting evidence for efficacy in the treatment of CIPN include topical pain relievers, such as baclofen/amitriptyline/ketamine gel, and serotonin and norepinephrine reuptake inhibitors, such as venlafaxine and duloxetine. Other promising therapies are also reviewed in this paper. Cutaneous electrostimulation is a nonpharmacological therapy that appears, from an early pilot trial, to be potentially effective in the treatment of CIPN. Finally, there is a lack of evidence of effective treatments for the paclitaxel acute pain syndrome (P-APS), which appears to be caused by neurologic injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02999.x · Cited by 1,873
Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment
Baron, R., Binder, A., & Wasner, G. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70143-5 · Cited by 1,816
The neuropathic pain triad: neurons, immune cells and glia
Scholz, J., & Woolf, C. J. (2007) · Nature Neuroscience · doi:10.1038/nn1992 · Cited by 1,732
Mechanisms of resistance to cisplatin
Kartalou, M., & Essigmann, J. M. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00141-5 · Cited by 869
Immune and inflammatory mechanisms in neuropathic pain
Moalem, G., & Tracey, D. J. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.11.004 · Cited by 774
Gastrosplenic Fistula From Hodgkin's Lymphoma
Seib, C. D., Rocha, F. G., Hwang, D. G., & Shoji, B. T. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.7695 · Cited by 735
Cytokines and their relationship to the symptoms and outcome of cancer
Seruga, B., Zhang, H., Bernstein, L. J., & Tannock, I. F. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2507 · Cited by 652
Chemotherapy‐induced neuropathy
Windebank, A. J., & Grisold, W. (2008) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2008.00156.x · Cited by 613
Postma, T. J., Aaronson, N. K., Heimans, J. J., Muller, M. J., Hildebrand, J. G., Delattre, J. Y., Hoang-Xuan, K., Lantéri-Minet, M., Grant, R., Huddart, R., et al. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.02.012 · Cited by 583
Flatters, S. J. L., & Bennett, G. J. (2006) · Pain · doi:10.1016/j.pain.2006.01.037 · Cited by 535
Rowbotham, M. C., Goli, V., Kunz, N. R., & Lei, D. (2004) · Pain · doi:10.1016/j.pain.2004.05.010 · Cited by 521
Cancer pain and its impact on diagnosis, survival and quality of life
Mantyh, P. W. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1914 · Cited by 441
Exercise training can modify the natural history of diabetic peripheral neuropathy
Balducci, S., Iacobellis, G., Parisi, L., Di Biase, N., Calandriello, E., Leonetti, F., & Fallucca, F. (2006) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2005.07.005 · Cited by 427
Cascinu, S., Catalano, V., Cordella, L., Labianca, R., Giordani, P., Baldelli, A. M., Beretta, G. D., Ubiali, E., & Catalano, G. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.061 · Cited by 421
Diagnosis, Management, and Evaluation of Chemotherapy-Induced Peripheral Neuropathy
Hausheer, F. H., Schilsky, R. L., Bain, S., Berghorn, E. J., & Lieberman, F. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.12.010 · Cited by 408
Calhoun, E. A., Welshman, E. E., Chang, C.-H., Lurain, J. R., Fishman, D. A., Hunt, T. L., & Cella, D. (2003) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2003.13603.x · Cited by 392
Immune regulation of central nervous system functions: from sickness responses to pathological pain
WATKINS, L. R., & MAIER, S. F. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01443.x · Cited by 366
Rao, R. D., Michalak, J. C., Sloan, J. A., Loprinzi, C. L., Soori, G. S., Nikcevich, D. A., Warner, D. O., Novotny, P., Kutteh, L. A., Wong, G. Y., et al. (2007) · Cancer · doi:10.1002/cncr.23008 · Cited by 360
Self-citationPrevention of Oxaliplatin-Related Neurotoxicity by Calcium and Magnesium Infusions
Gamelin, L., Boisdron‐Celle, M., Delva, R., Guerin‐Meyer, V., Ifrah, N., Morel, A., & Gamelin, E. C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0666 · Cited by 346
Watkins, L. R., Hutchinson, M. R., Ledeboer, A., Wieseler-Frank, J., Milligan, E. D., & Maier, S. F. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.10.011 · Cited by 326
Oxaliplatin-safety profile: neurotoxicity
GROTHEY, A. (2003) · Seminars in Oncology · doi:10.1016/s0093-7754(03)00399-3 · Cited by 319
Neuroprotective Effect of Vitamin E Supplementation in Patients Treated With Cisplatin Chemotherapy
Pace, A., Savarese, A., Picardo, M., Maresca, V., Pacetti, U., Del Monte, G., Biroccio, A., Leonetti, C., Jandolo, B., Cognetti, F., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.139 · Cited by 307
Sultan, A., Gaskell, H., Derry, S., & Moore, R. A. (2008) · BMC Neurology · doi:10.1186/1471-2377-8-29 · Cited by 291
Cella, D., Peterman, A., Hudgens, S., Webster, K., & Socinski, M. A. (2003) · Cancer · doi:10.1002/cncr.11578 · Cited by 286
Natural History of Paclitaxel-Associated Acute Pain Syndrome: Prospective Cohort Study NCCTG N08C1
Loprinzi, C. L., Reeves, B. N., Dakhil, S. R., Sloan, J. A., Wolf, S. L., Burger, K. N., Kamal, A., Le-Lindqwister, N. A., Soori, G. S., Jaslowski, A. J., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.0308 · Cited by 281
Self-citationPostma, T. J., Vermorken, J. B., Liefting, A. J. M., Pinedo, H. M., & Heimans, J. J. (1995) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a059220 · Cited by 271
Phillips, T. J. C., Cherry, C. L., Cox, S., Marshall, S. J., & Rice, A. S. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014433 · Cited by 255
Barton, D. L., Wos, E. J., Qin, R., Mattar, B. I., Green, N. B., Lanier, K. S., Bearden, J. D., Kugler, J. W., Hoff, K. L., Reddy, P. S., et al. (2011) · Supportive Care in Cancer · doi:10.1007/s00520-010-0911-0 · Cited by 255
Self-citationLindeman, E., Leffers, P., Spaans, F., Drukker, J., Reulen, J., Kerckhoffs, M., & Köke, A. (1995) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/s0003-9993(95)80629-6 · Cited by 239
Hammack, J. E., Michalak, J. C., Loprinzi, C. L., Sloan, J. A., Novotny, P. J., Soori, G. S., Tirona, M. T., Rowland, K. M., Stella, P. J., & Johnson, J. A. (2002) · Pain · doi:10.1016/s0304-3959(02)00047-7 · Cited by 231
Self-citationBroyl, A., Corthals, S. L., Jongen, J. L., van der Holt, B., Kuiper, R., de Knegt, Y., van Duin, M., el Jarari, L., Bertsch, U., Lokhorst, H. M., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70206-0 · Cited by 219
Richardson, J. K., Sandman, D., & Vela, S. (2001) · Archives of Physical Medicine and Rehabilitation · doi:10.1053/apmr.2001.19742 · Cited by 214
Amitriptyline in the Treatment of Chemotherapy-Induced Neuropathic Symptoms
Kautio, A.-L., Haanpää, M., Saarto, T., & Kalso, E. (2008) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2007.02.043 · Cited by 213
Wang, W.-S., Lin, J.-K., Lin, T.-C., Chen, W.-S., Jiang, J.-K., Wang, H.-S., Chiou, T.-J., Liu, J.-H., Yen, C.-C., & Chen, P.-M. (2007) · The Oncologist · doi:10.1634/theoncologist.12-3-312 · Cited by 210
Vitamin E for prophylaxis against chemotherapy-induced neuropathy: A randomized controlled trial
Argyriou, A. A., Chroni, E., Koutras, A., Ellul, J., Papapetropoulos, S., Katsoulas, G., Iconomou, G., & Kalofonos, H. P. (2005) · Neurology · doi:10.1212/01.wnl.0000148609.35718.7d · Cited by 209
Neurologic complications of chemotherapy agents
Kannarkat, G., Lasher, E. E., & Schiff, D. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3282f1a06e · Cited by 200
Grothey, A., Nikcevich, D. A., Sloan, J. A., Kugler, J. W., Silberstein, P. T., Dentchev, T., Wender, D. B., Novotny, P. J., Chitaley, U., Alberts, S. R., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.5911 · Cited by 198
Self-citationRao, R. D., Flynn, P. J., Sloan, J. A., Wong, G. Y., Novotny, P., Johnson, D. B., Gross, H. M., Renno, S. I., Nashawaty, M., & Loprinzi, C. L. (2008) · Cancer · doi:10.1002/cncr.23482 · Cited by 193
Self-citationTa, L. E., Bieber, A. J., Carlton, S. M., Loprinzi, C. L., Low, P. A., & Windebank, A. J. (2010) · Molecular Pain · doi:10.1186/1744-8069-6-15 · Cited by 193
Self-citationVitamin E neuroprotection for cisplatin neuropathy: A randomized, placebo-controlled trial
Pace, A., Giannarelli, D., Galiè, E., Savarese, A., Carpano, S., Della Giulia, M., Pozzi, A., Silvani, A., Gaviani, P., Scaioli, V., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d5279e · Cited by 191
Watkins, L. R., Hutchinson, M. R., Milligan, E. D., & Maier, S. F. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.06.006 · Cited by 185
Smyth, J. F., Bowman, A., Perren, T., Wilkinson, P., Prescott, R. J., Quinn, K. J., & Tedeschi, M. (1997) · Annals of Oncology · doi:10.1023/a:1008211226339 · Cited by 178
Peters, C. M., Jimenez-Andrade, J. M., Kuskowski, M. A., Ghilardi, J. R., & Mantyh, P. W. (2007) · Brain Research · doi:10.1016/j.brainres.2007.06.066 · Cited by 175
Jin, H. W., Flatters, S. J. L., Xiao, W. H., Mulhern, H. L., & Bennett, G. J. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.11.001 · Cited by 160
Pharmacogenomics of gemcitabine: can genetic studies lead to tailor-made therapy?
Ueno, H., Kiyosawa, K., & Kaniwa, N. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603860 · Cited by 158
Bianchi, G., Vitali, G., Caraceni, A. T., Ravaglia, S., Capri, G., Cundari, S., Zanna, C., & Gianni, L. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.04.028 · Cited by 152
Reduction of paclitaxel-induced peripheral neuropathy with glutamine.
Vahdat, L. T., Papadopoulos, K. P., Lange, D., Leuin, S. C., Kaufman, E. A., Donovan, D., Frederick, D., Bagiella, E., Tiersten, A., NICHOLS, G. L., et al. (2001) · PubMed · Cited by 149
Topical 2% Amitriptyline and 1% Ketamine in Neuropathic Pain Syndromes
Lynch, M. E., Clark, A. J., Sawynok, J., & Sullivan, M. J. L. (2005) · Anesthesiology · doi:10.1097/00000542-200507000-00021 · Cited by 144
Acupuncture Treatment for Chemotherapy-Induced Peripheral Neuropathy – a Case Series
Wong, R. K. W., & Sagar, S. M. (2006) · Acupuncture in Medicine · doi:10.1136/aim.24.2.87 · Cited by 139
Comparison of Oxaliplatin- and Cisplatin-Induced Painful Peripheral Neuropathy in the Rat
Joseph, E. K., & Levine, J. D. (2009) · Journal of Pain · doi:10.1016/j.jpain.2008.12.003 · Cited by 137
Thioctic Acid for Patients with Symptomatic Diabetic Polyneuropathy: A Critical Review
Ziegler, D. (2004) · Treatments in Endocrinology · doi:10.2165/00024677-200403030-00005 · Cited by 135
Preventing Paclitaxel-Induced Peripheral Neuropathy: A Phase II Trial of Vitamin E Supplementation
Argyriou, A. A., Chroni, E., Koutras, A. K., Iconomou, G., Papapetropoulos, S., Polychronopoulos, P., & Kalofonos, H. P. (2006) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2006.03.013 · Cited by 134
Leonard, D. R., Farooqi, M. H., & Myers, S. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.168 · Cited by 134
Chemotherapy-Induced Peripheral Neuropathy: A Review and Implications for Oncology Nursing Practice
Wickham, R. (2007) · Clinical journal of oncology nursing · doi:10.1188/07.cjon.361-376 · Cited by 119
Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy
Cavaletti, G., Bogliun, G., Marzorati, L., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh348 · Cited by 118
Maestri, A., Ceratti, A. D. P., Cundari, S., Zanna, C., Cortesi, E., & Crinò, L. (2005) · Tumori Journal · doi:10.1177/030089160509100206 · Cited by 113
Lin, P., Lee, M.-Y., Wang, W.-S., Yen, C., Chao, T., Hsiao, L., Yang, M., Chen, P., Lin, K., & Chiou, T.-J. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-006-0018-9 · Cited by 112
The Paclitaxel Acute Pain Syndrome: Sensitization of Nociceptors as the Putative Mechanism
Loprinzi, C. L., Maddocks‐Christianson, K., Wolf, S. L., Rao, R. D., Dyck, P. J. B., Mantyh, P. W., & Dyck, P. J. B. (2007) · The Cancer Journal · doi:10.1097/ppo.0b013e31815a999b · Cited by 108
Self-citationSmith, T. J., Coyne, P. J., Parker, G. L., Dodson, P. W., & Ramakrishnan, V. (2010) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2010.03.022 · Cited by 106
Johnson, D. C., Corthals, S. L., Walker, B. A., Ross, F. M., Gregory, W. M., Dickens, N. J., Lokhorst, H. M., Goldschmidt, H., Davies, F. E., Durie, B. G. M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.0792 · Cited by 104
Sloan, J. A., Berk, L. B., Roscoe, J. A., Fisch, M. J., Shaw, E. G., Wyatt, G. K., Morrow, G. R., & Dueck, A. C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.7670 · Cited by 102
Bianchi, R., Brines, M. L., Lauria, G., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2177 · Cited by 94
Role of pregabalin in treatment of oxaliplatin-induced sensory neuropathy.
Saif, M. W., Syrigos, K., Kaley, K., & Isufi, I. (2010) · PubMed · Cited by 91
Amitriptyline in the prevention of chemotherapy-induced neuropathic symptoms.
Kautio, A.-L., Haanpää, M. L., Leminen, A., Kalso, E. A., Kautiainen, H., & Saarto, T. (2009) · PubMed · Cited by 89
Immediate effects of anticancer drugs on mitochondrial oxygen consumption
Souid, A., Tacka, K. A., Galvan, K., & Penefsky, H. S. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00418-0 · Cited by 89
Argyriou, A. A., Polychronopoulos, P., Koutras, A. K., et al. (2005) · Supportive Care in Cancer · doi:10.1007/s00520-005-0868-6 · Cited by 84
Management of chemotherapy-induced peripheral neuropathy
Stillman, M. J., & Cata, J. P. (2006) · Current Pain and Headache Reports · doi:10.1007/s11916-006-0033-z · Cited by 83
Electrotherapy for the treatment of painful diabetic peripheral neuropathy – a review
Pieber, K., Herceg, M., & Paternostro‐Sluga, T. (2010) · Journal of Rehabilitation Medicine · doi:10.2340/16501977-0554 · Cited by 80
Moore, D. H., Donnelly, J. P., McGuire, W. P., Almadrones, L., Cella, D. F., Herzog, T. J., & Waggoner, S. E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.086 · Cited by 80
Effective Treatment of Oxaliplatin-Induced Cumulative Polyneuropathy With Alpha-Lipoic Acid
Gedlicka, C., Scheithauer, W., Schüll, B., & Kornek, G. V. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.99.502 · Cited by 72
Meyer, L., Patte‐Mensah, C., Taleb, O., & Mensah‐Nyagan, A. G. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0372-0 · Cited by 71
Milla, P., Airoldi, M., Weber, G., Drescher, A., Jaehde, U., & Cattel, L. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32832a2dc1 · Cited by 69
Durand, J.-P., Alexandre, J. R. M., Guillevin, L., & Goldwasser, F. O. (2005) · Anti-Cancer Drugs · doi:10.1097/00001813-200506000-00015 · Cited by 66
Acetyl-L-Carnitine in Neuropathic Pain: Experimental Data
Chiechio, S., Copani, A., Gereau, R. W., & Nicoletti, F. (2007) · CNS Drugs · doi:10.2165/00023210-200721001-00005 · Cited by 64
Callizot, N., Andriambeloson, E., Glass, J. D., Revel, M., Ferro, P., Cirillo, R., Vitte, P., & Dréano, M. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0689-7 · Cited by 63
Garrido, N., Martos, A. P., Faro, M., Lou-Bonafonte, J. M., Fernández‐Silva, P., López-Pérez, M. J., Montoya, J., & Enrı́quez, J. A. (2008) · Biochemical Journal · doi:10.1042/bj20071615 · Cited by 58
Wieseler‐Frank, J., Jekich, B. M., Mahoney, J. H., Bland, S. T., Maier, S. F., & Watkins, L. R. (2006) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.07.004 · Cited by 55
Weekly cisplatin ± glutathione in relapsed ovarian carcinoma
Colombo, N., BINI, S., Miceli, D. D., Bogliun, G., Marzorati, L., Cavaletti, G., Parmigiani, F., Venturino, P., Tedeschi, M., Frattola, L., et al. (1995) · International Journal of Gynecological Cancer · doi:10.1046/j.1525-1438.1995.05020081.x · Cited by 44
Improvement of Sensory Impairment in Patients with Peripheral Neuropathy
Prendergast, J. J., Miranda, G., & Sanchez, M. (2004) · Endocrine Practice · doi:10.4158/ep.10.1.24 · Cited by 43
Evidence for an antihyperalgesic effect of venlafaxine in vincristine-induced neuropathy in rat
Marchand, F., Alloui, A., Pélissier, T., Hernández, A., Authier, N., Álvarez, P., Eschalier, A., & Ardid, D. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02946-9 · Cited by 40
Erythropoietin Against Cisplatin-Induced Peripheral Neurotoxicity in Rats
Orhan, B., Yalçın, Ş., Nurlu, G., Zeybek, N. D., & Muftuoglu, S. F. (2004) · Medical Oncology · doi:10.1385/mo:21:2:197 · Cited by 28
Transitions of Care and Changes in Distressing Pain
Trask, P. C., Teno, J. M., & Nash, J. M. (2006) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2006.03.007 · Cited by 28
Rodriguez‐Menendez, V., Gilardini, A., Bossi, M., Canta, A., Oggioni, N., Carozzi, V., Tremolizzo, L., & Cavaletti, G. (2008) · PubMed · Cited by 24
Effect of mexiletine on vincristine-induced painful neuropathy in mice
Kamei, J., Nozaki, C., & Saitoh, A. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.02.033 · Cited by 23
Arnall, D. A., Nelson, A. G., López, L., et al. (2006) · Acta Diabetologica · doi:10.1007/s00592-006-0207-5 · Cited by 23
Cited by
Seretny, M., Currie, G. L., Sena, E. S., Ramnarine, S., Grant, R., MacLeod, M. R., Colvin, L. A., & Fallon, M. (2014) · Pain · doi:10.1016/j.pain.2014.09.020 · Cited by 1,555
Hershman, D. L., Lacchetti, C., Dworkin, R. H., Lavoie Smith, E. M., Bleeker, J., Cavaletti, G., Chauhan, C., Gavin, P., Lavino, A., Lustberg, M. B., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.0914 · Cited by 1,209
Self-citationRunowicz, C. D., Leach, C. R., Henry, N. L., Henry, K. S., Mackey, H. T., Cowens-Alvarado, R. L., Cannady, R. S., Pratt-Chapman, M. L., Edge, S. B., Jacobs, L. A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.3809 · Cited by 1,071
Mechanisms of Acupuncture–Electroacupuncture on Persistent Pain
Zhang, R., Lao, L., Ren, K., & Berman, B. M. (2014) · Anesthesiology · doi:10.1097/aln.0000000000000101 · Cited by 919
Runowicz, C. D., Leach, C. R., Henry, N. L., Henry, K. S., Mackey, H. T., Cowens‐Alvarado, R. L., Cannady, R. S., Pratt‐Chapman, M. L., Edge, S. B., Jacobs, L. A., et al. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21319 · Cited by 728
Metadata
- Authors
- Pachman, D. R., Barton, D. L., Watson, J. C., & Loprinzi, C. L.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2011-08-03
- Volume
- 90
- Issue
- 3
- Pages
- 377-387
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2082579490
- Cited by
- 268
- References
- 86
- FWCI
- 10.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.